Pasupati Fincap (511734)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹4.95 |
| Market Cap | ₹2.37 Cr |
| P/E Ratio | 0 |
| ROCE | -2,700% |
| ROE | 47.79% |
| Dividend Yield | 0% |
| Profit Growth | -300% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹9.09 — ₹29.7 |
| Sector | Finance |
Strengths
- At ₹4.95, the market capitalisation is only ₹2 crore, so absolute capital at risk is tiny for a speculative recovery.
- The reported ROE of 47.79%, while unreliable now, indicates that the equity base is small enough for a return to profit to move per-share numbers sharply.
- The absence of dividend outflow leaves whatever resources remain inside the company for any future revival.
Concerns
- Latest quarter sales are ₹0 crore and net profit is ₹-0 crore; the business is not generating current earnings.
- Profit growth is -300% and the Piotroski F-Score is 2/9, indicating severe financial deterioration.
- ROCE of -2,700% implies capital destruction; no value is being created from the asset base.
- Critical data—book value, P/B, debt/equity, and promoter holding—are unavailable, so no margin of safety can be calculated.
AI Analysis
At ₹4.95 Pasupati Fincap trades for a total market capitalisation of just ₹2 crore. But a low price is not the same as a bargain. For an NBFC, the first question is whether it can earn a spread on its capital. The latest quarter reports sales of ₹0 crore and a net profit of roughly ₹0 crore, while profit growth is -300%. That tells me the engine is not running. The reported ROE of 47.79% is meaningless when the earnings base has disappeared; it only reflects a tiny equity number. Meanwhile ROCE is -2,700%, which is the opposite of capital compounding. With a Piotroski F-Score of 2/9, seven of nine financial-health tests are failing. There is no dividend yield, no sales growth, no promoter holding data, and no book value or debt-equity figure to establish a Graham-style margin of safety. The share price is below the stated 52-week low of ₹9.09, which suggests either severely broken liquidity or unreliable pricing. In either case, I cannot determine intrinsic value. A sound investment requires evidence of earning power and trustworthy financials; this lacks both. The financial sector is built on trust and numbers, and here key numbers are N/A. I would file this under 'too hard.' If the business ever returns to meaningful revenue, positive net profit, and transparent disclosures, I will revisit. Until then, protecting capital means walking away. This is not investing; it is speculation.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer